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ABSTRACT: Diamine oxidase (DAO) is an enzyme involved in
the regulation of cell proliferation and the immune response. This
enzyme performs oxidative deamination in the catabolism of
biogenic amines, including, among others, histamine, putrescine,
spermidine, and spermine. The mechanistic details underlying the
reductive half-reaction of the DAO-catalyzed oxidative deamination
which leads to the reduced enzyme cofactor and the aldehyde
product are, however, still under debate. The catalytic mechanism
was proposed to involve a prototropic shift from the substrate−
Schiﬀ base to the product−Schiﬀ base, which includes the rate-
limiting cleavage of the Cα−H bond by the conserved catalytic aspartate. Our detailed mechanistic study, performed using a
combined quantum chemical cluster approach with empirical valence bond simulations, suggests that the rate-limiting cleavage of
the Cα−H bond involves direct hydride transfer to the topaquinone cofactora mechanism that does not involve the formation
of a Schiﬀ base. Additional investigation of the D373E and D373N variants supported the hypothesis that the conserved catalytic
aspartate is indeed essential for the reaction; however, it does not appear to serve as the catalytic base, as previously suggested.
Rather, the electrostatic contributions of the most signiﬁcant residues (including D373), together with the proximity of the Cu2+
cation to the reaction site, lower the activation barrier to drive the chemical reaction.
■ INTRODUCTION
Amine oxidases (AOs) are a group of enzymes that catalyze the
degradation of amines into the corresponding aldehydes with
the concomitant production of hydrogen peroxide and
ammonia, as shown in Scheme 1. They are divided into two
structurally distinct classes of enzymes, depending on the
cofactor involved in the oxidative deamination reaction:1−3 (i)
the copper-containing AOs [e.g., diamine oxidase (DAO)], and
(ii) the ﬂavin adenine dinucleotide-containing AOs [e.g.,
monoamine oxidase B (MAO B)]. Both DAO and MAO B
are involved in histamine degradation in the human body4 and
are thus crucial for the regulation of histamine at physiological
concentrations.
In the central nervous system, histamine degradation is
initiated by its methylation with histamine N-methyltransferase
(HNMT), producing N-methylhistamine, which is inactive at
the histamine receptor sites and which is further oxidized by
MAO B to the corresponding imine. The imine leaves MAO B
and undergoes non-enzymatic hydrolysis to the respective
aldehyde,5,6 which is rapidly further metabolized by aldehyde
dehydrogenase to t-methyl-imidazoleacetic acid (Scheme 2a).7
In contrast, in peripheral tissues, DAO acts directly on
histamine (Scheme 2b), yielding imidazoleacetic acid as the
end product of histamine degradation.7 Because of its broad
substrate speciﬁcity, including activity toward histamine-related
compounds such as N-methylhistamine,8 and others like
cadaverine (1,5-diaminopentane),9 putrescine (1,4-diaminobu-
tane),8 and the polyamine spermidine,8 DAO is a frontline
enzyme for the degradation of exogenous amines. Hence,
reduced levels of both DAO activity and expression have been
directly linked to histamine intolerance.4 This, in turn, leads to
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numerous unpleasant symptoms, including, for example,
diarrhea, headaches, nasal congestion, asthmatoid wheezing,
hypotension, and arrhythmia, as described in ref 4 and
references cited therein.
The DAO-catalyzed oxidative deamination consists of
reductive and oxidative half-reactions. While the former leads
to the reduced enzyme cofactor and the aldehyde product,10
the latter involves the reoxidation of the enzyme cofactor by
molecular oxygen, which produces ammonia and hydrogen
peroxide (Scheme 1). Measurements of primary kinetic isotope
eﬀects indicated that the rate-limiting step of these reactions is
the cleavage of the Cα−H bond.11 Oxidation of p-
dimethylaminomethylbenzylamine and its deuterated analogue
by DAO gave kH/kD values up to 5.5.
11 This led the authors to
propose a mechanism that involves the formation of a Schiﬀ-
base between the amine group of the substrate and the C5-
carbonyl atom of the 2,4,5-trihydroxy phenylalanine-quinone
(TPQ) cofactor (Scheme 3). The prototropic shift from the
substrate−Schiﬀ base to the product−Schiﬀ base includes the
rate-limiting cleavage of the Cα−H bond,11−14 as postulated in
a study where 2-hydroxy-5-tert-butyl-1,4-benzoquinone was
used as a model for the topaquinone (TPQ) cofactor to study
the mechanism of benzylamine oxidation in acetonitrile.12
According to the proposed mechanism (Scheme 3), benzyl-
amine and the model cofactor (TPQox) form a covalent
substrate−Schiﬀ base complex (TPQs−Sb), followed by the
base-catalyzed proton abstraction from the substrate−Schiﬀ
base complex, resulting in the product−Schiﬀ base complex
(TPQp−Sb). The product−Schiﬀ base complex is ﬁnally
hydrolyzed to an aldehyde and the aminoresorcinol form of
the reduced cofactor (TPQred). In the enzyme-catalyzed
reaction, a conserved aspartate residue was proposed to act as
the catalytic base.15
Extensive mutagenesis studies have indicated that D383 of
Escherichia coli AO (ecAO) is critical for this enzyme’s catalytic
activity.13,14 That is, the D383E variant showed very low, but
measurable, activity.13 The D383N and D383A variants were
inactive, with the former having drastically reduced aﬃnity for
the 2-hydrazinopyridine inhibitor, compared to the wild-type
(WT) enzyme.14 It was, therefore, concluded that D383
performs an essential role in catalysis, acting as the catalytic
base, allowing the conversion of a substrate−Schiﬀ to a
product−Schiﬀ base complex.
The role of the copper ion has also been extensively
studied,17,18 indicating its necessity for the catalytic mechanism
of these AOs. It was shown that the copper-free form of the
pig-kidney AO completely lost its activity.18 Upon the addition
of copper, however, the enzyme activity was fully restored.18 It
was also demonstrated that Ni2+ and Zn2+ do not bind the
protein, whereas Co2+ can be incorporated to the same extent
as Cu2+, but the Co-reconstituted enzyme shows only very
modest activity.18
The present study aims to elucidate the catalytic mechanism
of the oxidative deamination of histamine by human DAO
(hDAO) and to investigate the role of the catalytic D373
residue, which corresponds to D383 in the homologous
enzyme ecAO. To address these issues, we performed
quantum-mechanical (QM) cluster calculations of the enzyme
active site,19 followed by empirical valence bond (EVB)20−22
calculations of the full system that allowed us to calculate the
reaction free energies. Our calculations show that the rate-
limiting step of histamine degradation is the cleavage of the
Cα−H bond, as previously described.11 However, the reaction
proceeds via direct hydride transfer from histamine to the TPQ
cofactor, thus ruling out the previously proposed Schiﬀ-base
formation. Moreover, studies of the D373E and D373N
variants indeed prove that the conserved catalytic aspartate is
essential for the reaction, but it does not serve as the catalytic
base, as previously proposed.23 By describing the catalytic
mechanism of hDAO in detail, we provide a fundamental
understanding of this enzyme that is necessary for the design of
therapeutics for the treatment of histamine intolerance.4,24
■ RESULTS AND DISCUSSION
QM Cluster Models. As the starting point of this work, we
used QM cluster models of DAO, together with models of the
corresponding non-enzymatic reaction, to probe the proposed
mechanism of this enzyme through the formation of a
Scheme 2. Pathways for the Degradation of Histidine by the Enzymes: (a) MAO B and (b) DAO
Scheme 3. Proposed Mechanism for the Copper AO Catalyzed Oxidative Deamination of Amines, Adapted from Ref 16
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substrate−Schiﬀ base complex.12,25 Such models have been
used extensively to study enzymatic reaction mechanisms,19,26
as well as being the basis of the “theozymes” used for de novo
enzyme design purposes.27,28 Our initial model systems for the
non-enzymatic reaction included (i) histamine and the TPQ
cofactor as well as (ii) an extended model including histamine,
TPQ, and a Cu2+ ion. Both models were optimized at the
M11L/6-31G(d) level of theory, with the addition of the SDD
basis set for the extended model with copper. Using this
approach, it was not possible to obtain an optimized structure
for the substrate−Schiﬀ base complex in either the gas phase or
continuum solvent [using the conductor-like polarizable
continuum model (CPCM),29 with a dielectric constant of
80]. In all attempts to obtain this complex, potential energy
surface scanning resulted in quinone-ring opening, which
suggests that it is highly unlikely that such a substrate−Schiﬀ
base complex exists in the absence of the enzyme.
To examine whether this mechanism is possible in the hDAO
active site, we created a larger QM cluster model of the enzyme.
This model consisted of the histamine substrate, the Cu2+
cation, the TPQ cofactor, and the active site residues (i.e.,
D373, Y371, W376, Y459, H510, H512, and H675), as shown
in Figure 1. All amino acid side chains and the TPQ cluster
were truncated at the Cα-atom and capped with methyl groups.
The histamine was modeled in its neutral unionized form.
Although it has been shown that the substrate binds the active
site in its protonated form,30 the substrate needs to be
deprotonated to its unionized form to both restore its
nucleophilic character and initiate the reaction shown in
Scheme 3.31,32 Because the physiological pKa value of histamine
is around 9.4, the latter can easily be achieved by active site
water molecules with a cost of only a few kcal·mol−1.33 In
addition, the pKa of the 4-hydroxyl group of the TPQ cofactor
has been suggested to be as low as ∼3, which is in part due to
its proximity to the catalytic Cu2+ ion which will stabilize the
charge on the oxyanion and facilitate its deprotonation.34
Therefore, deprotonating the TPQ cofactor in the active site
will be facile, and in our simulations, it was modeled as an
oxyanion, because this form was shown to exist in the active site
even before the reaction occurs.35 The resulting cluster model
was embedded into continuum solvent, using the CPCM model
with a dielectric constant of 4.
Once the optimized reactant complex was obtained, we
performed an energy scan along the distance between the
nitrogen atom of the chain amino group of histamine and the
C5-carbonyl atom of the TPQ cofactor. As can be seen from
Figure S1, it was not possible to locate a transition state along
this reaction coordinate. We therefore examined other
mechanistic possibilities. Our previous computational work
on the related enzyme, MAO B, makes a one electron (radical)
pathway highly unlikely;36 we therefore focused on the direct
hydride transfer from the substrate Cα−H moiety to the DAO
cofactor, which is analogous to the mechanism proposed for the
MAO-catalyzed oxidative deamination of amine substrates.36−41
We note that it has been recently shown, both experimentally
and computationally, that C−H hydrogen bond donors directly
transfer the hydride anion to the carbonyl oxygen of 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone, which is often used
model quinone in mechanistic studies.42,43 Moreover, copper-
promoted hydride transfer to a carbonyl group was previously
reported as well.44 Therefore, we modeled the reaction where
Cα−H hydride cleavage from the histamine substrate involves a
direct transfer of the hydride anion (H−) to the carbonyl O5-
atom of the TPQ cofactor (Figure 2). QM calculations were
performed using the same cluster model of the enzyme as
described above. For the reaction coordinate, we selected the
distance between the donor Cα−H atom of the histamine and
the carbonyl O5 atom of the TPQ cofactor. All calculations
were performed at the (CPCM)/M11L/6-311++G(2df,2pd)-
SDD//(CPCM)/M11L/6-31G(d)-SDD level of theory, as
described in the Methodology section.
Figure 1. Structures of the (a) reactant, (b) intermediate, and (c) product states for the DAO-catalyzed oxidation of histamine obtained using a QM
cluster model to represent the active site of hDAO. Nonpolar hydrogen atoms have been omitted for clarity. Rather than annotating (and
overcrowding) the ﬁgure, the associated key distances are shown in Table S1, and the associated coordinates are also provided in the Supporting
Information.
Figure 2. Free energy proﬁle for the direct Cα−H hydride transfer in
hDAO-catalyzed deamination of histamine, obtained using a QM
cluster model (blue). The feasible, but slightly less favorable,
mechanistic alternative involving histamine deprotonation by the
side chain of the active site D373 in the second step of the reductive
half-reaction is shown in red. The experimental activation energy is
displayed in pink. All energies are in kcal·mol−1. A simpliﬁed version of
the cluster model used in the present work, showing only the main
reacting atoms, is also presented for clarity.
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Figure 2 shows the relevant QM-optimized stationary points
for the DAO catalyzed oxidative degradation of histamine. The
relevant interaction distances are shown in Table S1, and the
corresponding coordinates are provided in the Supporting
Information. In the reactant state, the histamine is oriented
toward the TPQ cofactor in a favorable conformation for the
reaction to occur, forming hydrogen bonds between its amino
group and the side-chain carboxylate of D373, as well between
the histamine-ring imino nitrogen and the side-chain oxygen
atom of Y459. The distances between the reacting atoms of
histamine and TPQ at the reactant state, i.e., Cα−O5 and Hα−
O5, are 3.2 and 2.6 Å, respectively. At the transition state, the
hydrogen being transferred is asymmetrically located between
the Cα-carbon and the O5-acceptor atom on the TPQ cofactor,
with Cα−H and O5−H distances of 1.4 and 1.1 Å, respectively.
We note here that the calculated activation free energy for this
process is 23.7 kcal·mol−1 (vimag = 1012i cm
−1), which is
signiﬁcantly higher than the experimental value (17.1 kcal·
mol−1,8 derived from the experimentally obtained kcat of 139
min−1, using the Eyring−Polanyi equation45), and therefore,
further EVB simulations20−22 were performed to probe this
reaction, as described in the next section. We, however, note
that the activation free energy of 23.7 kcal·mol−1 is comparable
to the value of 24.4 kcal·mol−1 for the analogous reaction in
MAO B that we previously obtained using the same QM-only
cluster approach.33
Natural bond orbital (NBO)46 analysis of the QM optimized
geometries demonstrates that this process is indeed associated
with the transfer of a hydride anion, as can be seen from the
calculated atomic charges (Table 1). In the reactant state, the
sum of the partial charges on the atoms of histamine and the
TPQ cofactor are 0.02 and −1.02, respectively. However, at the
transition state, the partial charges change to 0.25 and −1.25,
respectively, indicating a transfer of negative charge to the TPQ
cofactor. Following the hydride abstraction, the system
proceeds to the corresponding intermediates, characterized by
the semireduced TPQ cofactor and the cationic substrate
(Figures 1 and 2). The charge distribution further indicates that
the formation of the new O5−H bond increases the total
negative charge on the TPQ cofactor to −1.40, while
simultaneously the total positive charge on the histamine
increases to 0.80. The following step in the amine oxidation
involves deprotonation of the substrate amino group by the O2
atom of the TPQ cofactor (for a deﬁnition of the atom naming,
see Table 1). This step is facilitated by the increase in the
negative charge on the O2 atom of the TPQ cofactor during
the hydride transfer reaction. This process is calculated to have
a very low activation energy of 1.7 kcal·mol−1 (vimag = 1056i
cm−1) and is thus facile, making the initial hydride abstraction
the rate-limiting step of the overall reaction. Finally, the overall
reaction free energy (relative to the reactant state) is −2.5 kcal·
mol−1, resulting in a neutral trans-imine and fully reduced TPQ
cofactor as the ﬁnal products (Figure 2).
To explore the putative role of the active site residue D373 in
deprotonating the cationic substrate during the second step of
the reaction, as an alternative to the O2 atom of the TPQ
cofactor, we also examined this pathway (Figure 2). Our
calculations show that such a pathway is plausible, although the
reaction proceeds through the transition state with a notably
higher activation energy (4 kcal·mol−1 relative to the
intermediate and 9.7 kcal·mol−1 relative to the reactant state)
and with a slightly less stable product state (ΔG0 = 4.0 kcal·
mol−1). However, both pathways are substantially lower in
energy than the initial hydride transfer step and are therefore
likely to be viable options to complete the reaction.
EVB Simulations. While our calculations using the QM
cluster model strongly suggest that DAO utilizes a hydride
transfer mechanism similar to that in MAO B, the calculated
activation energy of 23.7 kcal·mol−1 is substantially higher than
the experimental value of 17.1 kcal·mol−1.8 This discrepancy
could, in part, be due to either an incomplete electrostatic
treatment in the continuum solvent model or due to insuﬃcient
conformational sampling. To address these issues, we
complemented our QM cluster calculations with EVB20−22
simulations using the two-state model described in Figure S2.
A fundamental part of the EVB philosophy is the need for a
well-deﬁned reference state, which can be either the non-
enzymatic reaction in vacuum or in solution or the WT enzyme
against a series of mutants (see detailed discussion in, e.g., refs
21, 22). The reference state is then parameterized to reproduce
either experimental data, where available, or higher-level QM
calculations, where experimental data is lacking. The obtained
Table 1. Charge Distribution of the Reacting Atoms during the Rate-Limiting Hydride-Abstraction Step in hDAO-Catalyzed
Histamine Oxidationa
aPartial charges were obtained by NBO analysis46 of the optimized geometries at the (CPCM)/M11L/6-31G(d)-SDD level of theory. b“Isolated”
refers to the charges of the isolated fragments at inﬁnite separation, and RS, TS, and IS indicate the corresponding reactant state, transition state, and
intermediate state, respectively.
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parameters are then transferred to describe the same chemical
reaction in diﬀerent environments. Such an approach is feasible
because of the demonstrated phase-independence of the EVB
oﬀ-diagonal elements, as validated in ref 47. In the present case,
due to the lack of experimental data to describe non-enzymatic
histamine degradation in aqueous solution, it is necessary to ﬁt
the non-enzymatic reference state to energies obtained from
higher-level QM calculations. For simplicity, we have
performed our reference calculations in vacuum to avoid
artifacts introduced by using continuum rather than explicit
solvation. We then performed EVB simulations in vacuum, as
described in the Methodology section, ﬁtting to the quantum
chemical calculations, and then using the same parameters to
study the reaction in solution and the DAO active site, as in
previous work.38,41 The vacuum energetics of the reaction were
calculated at the M11L/6-31G(d) level of theory, with zero-
point energies and entropies calculated from the vibrational
frequencies at the same level of theory as the geometry
optimizations. The model for the direct hydride transfer
reaction consisted of neutral histamine and TPQ cofactor with
a deprotonated hydroxyl group. The obtained transition state
was veriﬁed by frequency analysis (vimag = 745i cm
−1), as well as
by following the intrinsic reaction coordinate in the reactant
and product directions,48 which yielded an activation free
energy, ΔG⧧, of 51.5 kcal·mol−1, and a reaction free energy,
ΔG0, of 50.8 kcal·mol−1. These extremely large values are
consistent with the expectation that the investigated hydride
transfer would be extremely unfavorable in the gas phase.
The EVB free energies, obtained using the calibration
parameters shown in Table S2, are given in Figure 3a. As our
QM cluster calculations indicated that the hydride transfer is
the rate-limiting step of the overall process, we have focused
only on this step in our EVB calculations. From this data, it can
be seen that, as expected, the inclusion of solvent eﬀects already
substantially reduces the hydride transfer barrier even for the
non-enzymatic reaction. The barrier is further reduced in the
hDAO active site, yielding a calculated activation free energy of
14.8 kcal·mol−1. Previous studies have shown that protonated
histamine is likely bound to the active site; however,
deprotonated (neutral) histamine is essential for the reaction
to take place. Thus, an intraenzymatic deprotonation of
histamine must occur within the enzyme active site, the cost
of which would be expected to be 2.7 kcal·mol−1 at
physiological pH (assuming a pKa of 9.4 for histamine and
using the relationship ΔGPT = 2.303RT(pKa(donor) − pH)).
The cost of this deprotonation, which approximately equals the
diﬀerence between the calculated free energy of activation of
14.8 kcal·mol−1 and the experimental value of 17.1 kcal·mol−1
(derived from kcat = 139 min
−1),8 needs to be added to the
calculated value to account for the initial histamine
deprotonation. This yields an overall calculated free energy of
17.5 kcal·mol−1, in excellent agreement with the experimental
value, thus giving credence to our proposed mechanism (Table
2).
Finally, we note that our EVB calculations predict an
activation free energy of 26.6 kcal·mol−1 for the non-enzymatic
reaction in aqueous solution, leading to a barrier reduction of
11.8 kcal·mol−1 upon moving to the enzyme active site. This
would correspond to a tremendous rate acceleration of 109-fold
compared to the non-enzymatic reaction. This substantial rate
enhancement is comparable in magnitude to the similarly large
rate enhancement observed computationally in MAO B-
catalyzed dopamine oxidation, which has been demonstrated
to operate through the same direct hydride transfer
mechanism.38 The hydride transfer is also predicted to be
thermodynamically favorable, with a calculated reaction free
energy, ΔG0, of −2.9 kcal·mol−1.
Roles of D373 and the Metal Cofactor. Following from
our modeling of the WT enzyme, we have also investigated the
role of D373 in the catalytic mechanism by mutating this
residue both to glutamine and the isostructural, but chemically
distinct, asparagine (Figure 4). It was experimentally shown
that the D373E mutation leads to low but still detectable
activity, whereas the corresponding mutation to asparagine
completely abolishes the catalytic activity (Table 2).14 On the
Figure 3. Averaged EVB free-energy proﬁles (over 10 independent trajectories) for the reaction catalyzed by DAO in (a) vacuum, aqueous solution,
and the hDAO active site, and (b) WT hDAO and its D373E and D373N mutants. The generalized reaction coordinate (ΔE) is deﬁned by the
diﬀerence between the potential surfaces of the reactant and product states, as described in refs 21, 22.
Table 2. Catalytic Rate Constants (kcat), Experimental and
Calculated (EVB) Free Energies of Activation (ΔG⧧) and
Reaction (ΔG0) for Histamine Oxidation in Vacuum,
Aqueous Solution, and by the Selected DAO Variantsa
kcat ΔGexp⧧ ΔGcalc⧧ ΔΔG⧧ ΔG0,calc
vacuum b 51.5 ± 0.3 50.8 ± 0.2
water b 26.6 ± 0.2 15.6 ± 0.3
hDAO 139c 17.1 14.8 ± 1.0 0 −2.9 ± 1.5
D373E hDAO b 19.4 ± 0.1 4.6 14.1 ± 0.9
D373N hDAO b 29.1 ± 0.3 14.3 19.9 ± 0.3
ecAO 2073d 15.4 e 0
D383E ecAO 0.084d 21.5 e 6.1
aAll kcat values are shown in min
−1 and ΔG values are shown in kcal·
mol−1. ΔGexp⧧ values were computed from kcat using the Eyring−
Polanyi equation. Calculated free energies represent average values and
standard deviations over 10 independent EVB runs, performed as
described in the Methodology section. bExperimental data not
available. cExperimental data from ref 8. dExperimental data from ref
14, computed from the speciﬁc activity given in μmol·mg−1·mol−1,
with molecular weight taken from ecAO (PDB ID: 1SPU). eVariant
not simulated.
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basis of this, it has been proposed that D373 acts as the catalytic
base by abstracting proton from the substrate−Schiﬀ base
complex to produce the product−Schiﬀ base complex (Scheme
3, :B−). However, we demonstrate here (Table 2) that we
obtain good agreement with experiment when modeling this
reaction as proceeding through a direct hydride transfer
mechanism. Speciﬁcally, as can be seen from the obtained
EVB energetics, the calculated activation free energy for the
rate-limiting step of direct hydride transfer in the D373N
hDAO variant is 29.1 kcal·mol−1, which is a loss in activity of
approximately 10 orders of magnitude compared to that
calculated for the WT enzyme (with ΔGcalc⧧ = 14.8 kcal·mol−1).
Also, there is an extremely high thermodynamic barrier to this
process, as reﬂected in the reaction free energy of 19.9 kcal·
mol−1. Therefore, our calculations predict a complete loss of
activity for this variant, based on the direct hydride transfer
mechanism. Following from this, in the case of the D373E
variant, we calculate an activation free energy of 19.4 kcal·
mol−1, in reasonable agreement with the experimental value of
21.5 kcal·mol−1 for ecAO.14 We also note that in the case of
ecAO, this mutation increases the activation free energy by 6.1
kcal·mol−1. While we do not have the corresponding
experimental value for the hDAO mutants, our calculated
ΔΔGcalc⧧ of 4.6 kcal·mol−1 for mutant versus WT hDAO is in
good agreement with the observations from E. coli (where
ΔΔGexp⧧ is 6.1 kcal·mol−1). Here, we take into account that, as
shown in Table 2, WT hDAO is less active than the
corresponding enzyme from E. coli.
From a structural perspective, our EVB simulations show
that, in the calculated transition states (Figure 4a), D373 forms
hydrogen bonds with the amino group of histamine (average
distance 2.7 ± 0.1 Å and average angle 165.4 ± 7.9°) and with
the side chain of Y463 (2.7 ± 0.1 Å). In the transition state of
the D373E mutant, however, E373 forms hydrogen bonds
primarily with W376 (2.8 ± 0.2 Å) and Y463 (2.6 ± 0.1 Å),
thus bridging the two residues and not being engaged in
hydrogen bonding with amino group of histamine (3.0 ± 0.2 Å
and 142.7 ± 13.8°), which implies that this hydrogen bond is
lost at the transition state. At the same time, the average
distance between the cofactor TPQ:O2 and Cu2+ cation is 2.10
± 0.03 Å for WT DAO in contrast to 3.7 ± 0.2 Å for D373E.
This distance further increases to 4.4 ± 0.1 Å for the D373N
mutant (Figure 4). The electrostatic contributions of the most
signiﬁcant residues (Figure 5) show that the protein residue at
position 373 (i.e., D in the wild type, E or N in mutants) aﬀects
catalysis the most (while some other residues also make
contributions, as annotated in this ﬁgure, the contributions are
similar between the diﬀerent enzyme variants, and mostly
cancel each out). Thus, the diﬀerence in the free energy of
activation between the WT and D373E or D373N mutant
enzyme may be explained by a combination of the loss of
stabilizing interactions from the catalytic Cu2+ cation, together
with (in the case of the N373 variant) a slight loss of stabilizing
interaction from D373, which in turn leads to the loss of
activity.
■ CONCLUSIONS
In this work, we combined QM cluster calculations and EVB
simulations to elucidate the catalytic mechanism of the DAO
catalyzed oxidative deamination of histamine. Our results
indicate that direct hydride transfer from the substrate Cα−H
moiety to the O5 atom of TPQ cofactor is the rate-limiting step
of the reductive half-reaction, which is in line with the
experimentally conﬁrmed rate-limiting step. EVB simulations of
the hydride transfer reaction catalyzed by WT DAO predict an
almost 9 orders of magnitude rate enhancement in comparison
to the corresponding non-enzymatic reaction in aqueous
solution. The same rate enhancement was observed for the
equivalent reaction catalyzed by the MAO B enzyme on
monoamines.38 Moreover, we have also shown that while D373
is indeed essential for DAO catalysis, its role is not proton
abstraction during the catalytic cycle, as previously pro-
posed.12−14 Namely, the average hydrogen bond distances at
the transition state combined with the electrostatic contribu-
Figure 4. Representative EVB transition state structures for the
reactions catalyzed by (a) WT hDAO and its (b) D373E and (c)
D373N mutants in complex with histamine. The average distances
between the active site residues, computed over the TS trajectory, are
shown in Å, and the complete statistics is provided in Table S3.
Figure 5. Electrostatic contributions of the most signiﬁcant residues
(with a contribution >1 kcal·mol−1) to the calculated activation free
energies (ΔΔGelec,RS→TS⧧ ) of the hDAO-catalyzed direct hydride
transfer reaction. The depicted values were obtained by applying the
linear response approximation to the calculated EVB trajectories and
scaled by assuming an active site dielectric constant of 4, as in our
previous work (ref 49).
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tions of the most signiﬁcant residues (in terms of energetic
contributions) to the calculated activation free energies showed
that proximity of the Cu2+ cation, together with the residue
D373, aﬀect catalysis the most, with the loss of key interactions
with these moieties leading to the observed loss of activities in
the D373E and D373N variants. In conjunction with our
previous work,40 the results presented here suggest that the in
vivo degradation of histamine to yield an aldehyde always
occurs via the same catalytic mechanism, namely direct hydride
transfer from histamine and N-methylhistamine to the
corresponding cofactor (TPQ or FAD, respectively), regardless
of the histamine catabolic pathway. A detailed understanding of
the mechanism of histamine-degrading enzymes is important
for the design of therapeutics for the treatment of histamine
intolerance, bearing in mind that no medication to date is able
to increase DAO activity and therefore keep the level of
histamine degradation in balance. Insuﬃcient histamine
degradation by DAO however may also disrupt the other
histamine-degrading pathway operating through HNMT and
MAO B, resulting in the collapse of histamine clearance.50,51
Therefore, the catalytic mechanism of the degradation of this
possibly harmful compound is important for the successful
development of drugs that could supplement impaired
histamine-degradation pathways.
■ METHODOLOGY
QM Calculations. The cluster model of the DAO active site
used in this work consisted of the substrate histamine, the Cu2+
cation, the TPQ cofactor, and the active site residues D373,
Y371, W376, Y459, H510, H512, and H675, as shown in Figure
1. Geometries for all key stationary points were optimized using
the M11L functional52 at the M11L/6-31G(d) level of theory,
with the thermal Gibbs free energy corrections extracted from
frequency calculations at the same level of theory without
scaling factors applied. A further single point calculation was
performed with the larger 6-311++G(2df,2pd) basis set to
reﬁne the electronic energies. The results of these calculations
are shown in Figure 2 and Table S4.
System Setup for the EVB Simulations. To calibrate our
EVB simulations of the enzyme catalyzed reactions, we
performed corresponding simulation of the non-enzymatic
reaction in vacuum. The EVB gas-phase shift and coupling
parameters (α2
0 and H12, Table S2) were obtained by ﬁtting
these simulations to ΔG⧧ and ΔG0 obtained from QM
calculations in vacuum at the M11L/6-31G(d) level of theory
and then using the same parameter set for the reactions in
aqueous solution and in the enzyme active site. All QM
calculations are performed using the Gaussian 09 package.53
The starting points for our EVB simulations of DAO were
the coordinates of DAO in complex with the inhibitor
aminoguanidine (PDB ID: 3MPH).54 The D373E and
D373N mutants of DAO were generated using the Dunbrack
backbone-dependent rotamer library,55 as implemented in
Chimera.56 The position of the inhibitor in this structure
served as a reference point for initial manual positioning of the
substrate (i.e., histamine) into the hDAO active site. Short MD
simulations of 5 ns were then performed to obtain equilibrated
and optimized structures, which served as a starting point for
the subsequent protein parameterization. The protein model
included one subunit of hDAO enclosed in a simulation sphere,
with a 30 Å radius, centered at the reactive Cα of the substrate.
All protein atoms outside this sphere were kept restrained to
their starting positions by applying a 200 kcal·mol−1·Å−2
harmonic restraint. All ionized residues in simulations are
listed in Table S5. Other ionizable residues outside this region
were kept in their neutral state. All simulations were performed
using the OPLS-AA force ﬁeld,57,58 and the copper ion in this
enzyme was reparametrized to reproduce the correct
tetrahedral coordination, based on the previously published
copper dummy model by Liao et al.59 This model has been
successful in reproducing the Jahn−Teller eﬀect seen in
divalent copper and was deemed an excellent starting point
for the reparametrization.
All molecular dynamics and EVB simulations in this work
were performed using the Q (v5.10) simulation package.60 The
resulting structure of DAO in complex with histamine was
equilibrated and gradually heated to 300 K over a short 25 ps
simulation. The system was further equilibrated at 300 K,
performing 10 ns of MD simulation starting at the transition
state, for each reaction. An initial 200 kcal·mol−1·Å−2 harmonic
restraint was applied on all heavy atoms in the simulation
sphere to remove bad contacts. This was gradually reduced
during the initial heating phase, while only a 0.5 kcal·mol−1·Å−2
restraint was left on the reacting atoms of the substrate
histamine and TPQ cofactor. All solvent hydrogen atoms were
constrained by the SHAKE algorithm,61 and system temper-
atures were regulated using the Berendsen thermostat62 with a
100 fs bath relaxation time. For the calculation of all
nonbonded interactions, a cut-oﬀ value of 10 Å was used,
with the exception of those involving reacting atoms for which
a 99 Å cut-oﬀ (i.e., no cut-oﬀ) was used. The endpoint structure
of the equilibration run was used as a starting point for the
subsequent EVB simulations. The equilibrated structure was
subjected to 10 parallel FEP runs by randomizing the atomic
velocities to perform independent EVB calculations and ensure
reliable sampling. The mapping procedure was performed in 51
mapping frames of 100 ps each, yielding a total simulation time
of 5.1 ns per replica.
Substrate and Cofactor Parameterization. The program
Q,60 used for the EVB simulations, and GROMACS,63 which
was employed in the original Cu-model paper, use diﬀerent
force ﬁeld descriptions and the former does not apply particle
mesh Ewald summation for the long-range electrostatic
interactions. Therefore, the published Cu parameters were
further validated and optimized to allow a better ﬁt with the
previous experimental data.64 For the new parameters, both the
repulsive and attractive parts of the center particle of the ion
model were optimized in respect to the resulting hydration free
energies and ion−water radial distribution functions. It was also
necessary to reduce the repulsive force on the non-interacting
dummy particles from the 0.03 kcal·mol−1·Å−6, used in the
previous dummy model paper,65 to 0.01 kcal·mol−1·Å−6, or the
reproduction of the Jahn−Teller distortions was not possible.
This setup is in line with the results obtained in the original
article with GROMACS, where no force at all was applied to
the dummy particles. This approach was not chosen to avoid
singularities when calculating the forces in Q.
The parameterization was performed using the TIP3P water
model as implemented in Q, with the dummy model being
solvated in an 18 Å water sphere subjected to the spherical
boundary conditions, according to the surface-constrained all-
atom solvent model.66 Hydrogen atoms were subjected to the
SHAKE algorithm, with long-range interactions beyond a cut-
oﬀ of 10 Å being treated using the LRF approach.67 The metal
dummy was kept in the simulation sphere by applying a weak
position restraint of 0.5 kcal·mol−1·Å−2. After relaxing the
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system by gradually increasing temperature over the course of
60 ps, the ﬁnal coordinates were used to start ﬁve independent
calculations of the solvation free energy, using 51 umbrella-
sampling windows of 100 ps simulation time each (5.1 ns
simulation time per trajectory). The analysis of the free energies
was performed using the Qfep tool of the Q program suite. The
radial distribution function was calculated, from three 1 ns-long
independent MD simulations, using VMD (1.9.1),68 employing
a bin size of 0.01 and a cut-oﬀ of 10 Å (Figure S3).
The parameters for nonstandard protein residues (substrate
and cofactor) were obtained using the ﬄd_server as
implemented in Schrödinger’s Macromodel suite69 allowing
for the construction of the relevant EVB force ﬁelds to correctly
describe the reactant and product states of the hDAO-catalyzed
reaction (Tables S6−S10). For both states, atomic charges were
determined by ﬁtting to the electrostatic potentials computed
by the QM calculations at the HF/6-31G(d) level of theory
according to the RESP scheme, as implemented in
AmberTools15.70
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acsomega.8b00346.
Additional computational data and all parameters
necessary to reproduce our EVB simulations (PDF)
■ AUTHOR INFORMATION
Corresponding Authors
*E-mail: robert.vianello@irb.hr (R.V.).
*E-mail: kamerlin@icm.uu.se (S.C.L.K.).
ORCID
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